Mpox Vaccine: U.S. Government Research Update
A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.
Community Based Organizations
Back to Results
Mpox Surveillance: U.S. Government Research Update
A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science.
Injection Drug Use (IDU) Infographic
This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),
If You’re Not Seeing It Yet, You Will: Collaborating to Address Syphilis Among People Who Use Drugs
The Syphilis and Drug User Health Webinar Series consists of five monthly sessions where those working on STIs – specifically syphilis – and those working in harm reduction or drug user health will be brought together to learn from each other, share promising practices, and highlight effective cross-sector partnerships.
Hepatitis Can’t Wait: Using the Global Health Sector Strategy and its 2025 Targets to Drive Change
This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets.
The progress countries have made to these goals and what needs to be done to achieve them.
How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.
Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.
Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support applications for epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis (TB). Investigators should propose additional testing and data collection in existing cohorts of adult and/or pediatric TB participants to better characterize and understand adverse outcomes and morbidity associated with TB disease post treatment in individuals with and without HIV infection.
Audience Response Pages: Sex Worker Health & Harm Reduction 101
This engagement guide is meant to accompany the Slide Deck for “Sex Worker Health & Harm Reduction 101," developed by Reframe Health and Justice for NASTAD in the fall of 2022.
Sex Worker Health & Harm Reduction 101
This handout is meant to accompany the Slide Deck for “Sex Worker Health & Harm Reduction 101," developed by Reframe Health and Justice for NASTAD in the fall of 2022.
Facilitators' Guide: Sex Worker Health & Harm Reduction 101
This facilitator's guide is meant to accompany the Slide Deck for “Sex Worker Health & Harm Reduction 101," developed by Reframe Health and Justice for NASTAD in the fall of 2022.
Facilitators' Guide: Sex Worker Health & Harm Reduction 101
This facilitator's guide is meant to accompany the Slide Deck for “Sex Worker Health & Harm Reduction 101," developed by Reframe Health and Justice for NASTAD in the fall of 2022.